Shengda Announces March 2026 Revenue of NT$570 Million, Up 2.8% Year-on-Year
Shengda (stock code: 1720) reported its March 2026 revenue at NT$570.224 million, marking a 2.8% increase compared to the same period last year. This growth in the biotechnology and medical sector highlights the company's steady performance.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 17:20 (50 min after Collected)
Company Code: 1720
Company Name: Shengda
Industry: Biotechnology and Medical
Data Month: 2026-03
Monthly Revenue: 570,224 thousand yuan (NT$570 million)
Year-on-Year Change: +2.8%
Company Name: Shengda
Industry: Biotechnology and Medical
Data Month: 2026-03
Monthly Revenue: 570,224 thousand yuan (NT$570 million)
Year-on-Year Change: +2.8%
FAQ
What was Shengda's revenue for March 2026?
Shengda's revenue for March 2026 was 570,224 thousand yuan (0.57 billion yuan).
What was the year-on-year change in revenue?
It was an increase of +2.8% compared to the same month last year.
What kind of business does Shengda operate?
Shengda operates in the biotechnology and medical industry, dealing with pharmaceuticals and medical devices.